A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,400 shares of SRPT stock, worth $178,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,400
Previous 4,381 68.04%
Holding current value
$178,094
Previous $567,000 61.02%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$113.33 - $163.85 $337,836 - $488,436
-2,981 Reduced 68.04%
1,400 $221,000
Q1 2024

Apr 19, 2024

SELL
$93.7 - $141.53 $212,792 - $321,414
-2,271 Reduced 34.14%
4,381 $567,000
Q4 2023

Jan 30, 2024

SELL
$67.31 - $124.76 $90,195 - $167,178
-1,340 Reduced 16.77%
6,652 $641,000
Q3 2023

Oct 30, 2023

BUY
$102.5 - $123.59 $222,630 - $268,437
2,172 Added 37.32%
7,992 $968,000
Q2 2023

Jul 31, 2023

SELL
$106.4 - $157.19 $74,692 - $110,347
-702 Reduced 10.76%
5,820 $666,000
Q1 2023

Apr 27, 2023

SELL
$117.53 - $155.99 $327,085 - $434,120
-2,783 Reduced 29.91%
6,522 $898,000
Q4 2022

Jan 30, 2023

SELL
$100.86 - $132.13 $8,169 - $10,702
-81 Reduced 0.86%
9,305 $1.21 Million
Q3 2022

Oct 21, 2022

SELL
$75.71 - $119.24 $158,688 - $249,927
-2,096 Reduced 18.25%
9,386 $1.04 Million
Q2 2022

Jul 26, 2022

SELL
$62.69 - $88.44 $12,287 - $17,334
-196 Reduced 1.68%
11,482 $861,000
Q1 2022

Apr 27, 2022

SELL
$63.15 - $90.42 $34,606 - $49,550
-548 Reduced 4.48%
11,678 $912,000
Q4 2021

Feb 02, 2022

SELL
$77.28 - $99.42 $36,785 - $47,323
-476 Reduced 3.75%
12,226 $1.1 Million
Q3 2021

Oct 25, 2021

SELL
$65.97 - $92.48 $1.27 Million - $1.79 Million
-19,314 Reduced 60.33%
12,702 $1.18 Million
Q2 2021

Aug 02, 2021

SELL
$69.38 - $86.75 $28.8 Million - $36 Million
-415,139 Reduced 92.84%
32,016 $2.49 Million
Q1 2021

Apr 30, 2021

BUY
$72.25 - $168.95 $8.28 Million - $19.4 Million
114,642 Added 34.48%
447,155 $33.3 Million
Q4 2020

Feb 05, 2021

SELL
$125.56 - $178.74 $392,500 - $558,741
-3,126 Reduced 0.93%
332,513 $56.7 Million
Q3 2020

Oct 30, 2020

SELL
$127.12 - $172.34 $6.1 Million - $8.26 Million
-47,952 Reduced 12.5%
335,639 $47.1 Million
Q2 2020

Jul 27, 2020

SELL
$93.0 - $171.7 $2.5 Million - $4.62 Million
-26,893 Reduced 6.55%
383,591 $61.5 Million
Q1 2020

Apr 27, 2020

BUY
$82.38 - $131.64 $514,545 - $822,223
6,246 Added 1.55%
410,484 $40.2 Million
Q4 2019

Jan 31, 2020

SELL
$76.53 - $135.58 $83,723 - $148,324
-1,094 Reduced 0.27%
404,238 $52.2 Million
Q3 2019

Oct 31, 2019

BUY
$72.81 - $156.91 $23.1 Million - $49.9 Million
317,840 Added 363.28%
405,332 $30.5 Million
Q2 2019

Jul 29, 2019

BUY
$112.21 - $151.95 $5.05 Million - $6.84 Million
45,024 Added 106.02%
87,492 $13.3 Million
Q1 2019

May 08, 2019

BUY
$106.67 - $151.68 $4.53 Million - $6.44 Million
42,468 New
42,468 $5.06 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.1B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.